Ontogeny of cytosolic proteins capable of modulating sarcoplasmic reticulum calcium transport in heart muscle.
In a previous study we described the inhibitory action of a cytosolic protein fraction from heart muscle on ATP-dependent Ca2+ uptake by sarcoplasmic reticulum (SR); further, this inhibition was shown to be blocked by an inhibitor antagonist, also derived from the cytosol (Narayanan et al. Biochim Biophys Acta 735: 53-66, 1983). The present study investigated the ontogenetic expression of the activities of Ca2+ transport inhibitor and inhibitor antagonist in heart cytosol during fetal and postnatal development of the rat. The SR Ca2+ transport inhibitor activity was undetectable in the cytosol of fetal (15- or 20-days gestation) rat heart but was manifested in the cytosol as early as one day after birth and increased progressively thereafter to reach almost adult levels within the first two weeks of postnatal development. The activity of the SR Ca2+ transport inhibitor antagonist was barely detectable in the near-term (20 days gestation) fetus but increased substantially during early postnatal development, in parallel with the rise in activity of the inhibitor. The ontogenetic appearance and increase in the activities of the Ca2+ transport inhibitor and its antagonist correlated well with the concurrent appearance and increase in the amounts of two polypeptides of apparent molecular weights 43 kDa and 64 kDa, which we have tentatively identified as the inhibitor and inhibitor antagonist, respectively. The co-ordinated expression of both the inhibitor and inhibitor antagonist activities in the cytosol during the early postnatal period parallels the morphogenesis and functional maturation of SR in cardiac muscle suggesting likely involvement of these cytosolic proteins in the physiological regulation of SR function.
Donat
M E
ME
Department of Physiology, University of Western Ontario, London, Canada.
Su
N
N
Narayanan
N
N
D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development / Q000378:metabolism; D001692:Biological Transport; D002118:Calcium / Q000037:antagonists & inhibitors / Q000378:metabolism*; D003600:Cytosol / Q000737:chemistry*; D005314:Embryonic and Fetal Development; D005260:Female; D006321:Heart / Q000187:drug effects / Q000196:embryology*; D009124:Muscle Proteins / Q000302:isolation & purification / Q000502:physiology*; D009206:Myocardium / Q000737:chemistry / Q000378:metabolism*; D010455:Peptides / Q000737:chemistry; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism*
D009124:Muscle Proteins; D010455:Peptides; D002118:Calcium